BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:DJI136 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of DJI136\, from ClinicalTrials.gov estimate
 s.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07564401-11249@assetmemo.bio
DTSTAMP:20261121T005355Z
DTSTART;VALUE=DATE:20310303
DTEND;VALUE=DATE:20310304
SUMMARY:DJI136: Phase 1/2 readout est. (NCT07564401)
DESCRIPTION:DJI136\, phase 1/2\, Small Cell Lung Cancer.\nStudy: A Study to
  Evaluate DJI136\, a DLL3-targeted CAR-T Therapy\nEstimated primary comple
 tion: 3 March 2031. This is a ClinicalTrials.gov estimate\, not a confirme
 d readout date\, and it can move.\nDrug page: https://assetmemo.bio/drug/d
 ji136#upcoming-events\nRegistry record: https://clinicaltrials.gov/study/N
 CT07564401
URL:https://assetmemo.bio/drug/dji136#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
